Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility

Journal of Perinatology volume 32, pages 899–900 (2012)Cite this article

Subjects

Abstract

We describe the use of tin-mesoporphyrin (SnMP) in the treatment of an infant with Rh hemolytic disease. The infant's hyperbilirubinemia responded to phototherapy but every time the phototherapy was discontinued, the serum bilirubin rebounded and repeat phototherapy was necessary. A single intramuscular dose of SnMP on day 18 eliminated the need for further phototherapy and allowed us to discharge this infant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kappas A . A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 2004; 113: 119–123.

    Article  Google Scholar 

  2. Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH . Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 2006; 165: 306–319.

    Article  Google Scholar 

  3. Valaes T, Drummond GS, Kappas A . Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 1998; 101 (5): e1.

    Article  CAS  Google Scholar 

  4. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A . Control of jaundice in preterm newborns by an inhibitor of bilirubin production: Studies with tin-mesoporphyrin. Pediatrics 1994; 93: 1–11.

    CAS  PubMed  Google Scholar 

  5. Martinez JC, Garcia HO, Otheguy L, Drummond GS, Kappas A . Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999; 103: 1–5.

    Article  CAS  Google Scholar 

  6. Bhutani VK, Meloy LD, Poland RL, Hegyi T, Maisels MJ, Fanaroff AA et al. Randomized placebo-controlled clinical trial of stannsoporfin (Sn-MP) to prevent severe hyperbilirubinemia in term and near-term infants. Pediatr Res 2004; 55: 448A.

    Google Scholar 

  7. Kappas A, Drummond GS, Valaes T . A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns. Pediatrics 2001; 108 (1): 25–30.

    Article  CAS  Google Scholar 

  8. Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T . Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs’-positive ABO incompatibility. Pediatrics 1988; 81: 485–497.

    CAS  PubMed  Google Scholar 

  9. Kappas A, Drummond G, Henschke C, Valaes T . Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics 1995; 95: 468–474.

    CAS  PubMed  Google Scholar 

  10. Kappas A, Drummond GS, Munson DP, Marshall JR . Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Pediatrics 2001; 108: 1374–1377.

    Article  CAS  Google Scholar 

  11. Tulloch S . Personal Communication. Infacare Pharmaceutical 2011.

  12. Kaplan M, Kaplan E, Hammerman C, Algur N, Bromiker R, Schimmel MS et al. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child 2006; 91: 31–34.

    Article  CAS  Google Scholar 

  13. Maisels MJ, Kring E . Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med 2002; 156: 669–672.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Jon F Watchko, MD, for his review of this manuscript.

Author information

Authors and Affiliations

  1. Division of Neonatology, Department of Pediatrics, Oakland University William Beaumont School of Medicine, Beaumont Children's Hospital, Royal Oak, MI, USA

    M J Maisels & H Yang

Authors
  1. M J Maisels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M J Maisels.

Ethics declarations

Competing interests

Dr Maisels has acted as a consultant for InfaCare Pharmaceutical Corporation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maisels, M., Yang, H. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility. J Perinatol 32, 899–900 (2012). https://doi.org/10.1038/jp.2012.45

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2012.45

Keywords

This article is cited by

Search

Advanced search

Quick links